GREENSPAN IRA SCOTT purchased 18.6% of their position (1.22K shares) of SCOPUS BIOPHARMA INC. on the open market
Open‑market purchase worth $11.1K — a significant purchase. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 2/26/2021ACC: 0001104659-21-028948
+1.22K
Net shares
Net buyer
$11.1K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
1.22K acquired
Non-Derivative Transactions3
Common Stock, par value $0.001
Direct
Shares
+115.00
Price / share
$9.48
Trade value
$1.09K
% of position
0.1%
2/24/2021
80.67K→80.79K
Common Stock, par value $0.001
Indirect
Shares
+300.00
Price / share
$9.45
Trade value
$2.83K
% of position
4.5%
2/24/2021
6.65K→6.95K
Common Stock, par value $0.001
Indirect
Shares
+800.00
Price / share
$9.01
Trade value
$7.21K
% of position
11.5%
2/25/2021
6.95K→7.75K
Total
Net shares
+1.22K
Net value
$11.13K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 Direct | 2/24/2021 | P · Purchase | +115.00 | $9.48 | $1.09K | 0.1% | 80.67K | 80.79K |
| Common Stock, par value $0.001 Indirect | 2/24/2021 | P · Purchase | +300.00 | $9.45 | $2.83K | 4.5% | 6.65K | 6.95K |
| Common Stock, par value $0.001 Indirect | 2/25/2021 | P · Purchase | +800.00 | $9.01 | $7.21K | 11.5% | 6.95K | 7.75K |
| Total | +1.22K | $11.13K | ||||||
Derivative Transactions0
No derivative transactions reported